After the broader market declined on Monday and Tuesday, it ticked higher during the second half of the week and finished about flat. This puts major market indices up significantly year to date. The S&P 500, for instance, is up 25% so far this year and is …
See Original Article
It was weirdly cold in the room â that was the only thing everyone could agree on. Somehow, despite the bright lights and television cameras in the
See Original Article
Michael Bloomberg vowed Thursday [Dec. 5] to reinstitute a federal assault weapons ban and require more rigorous background checks and licensing
See Original Article
(Reuters) – Nearly half of lymphoma patients treated with Gilead Sciences Inc’s Yescarta were alive at least three years after a one-time infusion of the CAR-T cell therapy, according to data presented on Saturday. FILE PHOTO: A Gilead Sciences, Inc. logo is …
See Original Article
Leave a Reply